ARTICLE | Product Development
Companies poised to take Chinese checkpoints global
Three companies poised to answer Pazdur’s call for Chinese PD-1 inhibitors
April 19, 2019 11:41 PM UTC
At least three companies are well positioned to answer FDA Oncology chief Richard Pazdur’s call to bring Chinese PD-1/PD-L1 inhibitors to the U.S. to compete on price.
Two Chinese drugmakers and one U.S. company globally developing therapies from China have plans underway to bring Chinese PD-1 inhibitors to the U.S. ...